Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,200 | 2 | 66.8% |
| Travel and Lodging | $1,931 | 7 | 24.8% |
| Food and Beverage | $479.35 | 11 | 6.2% |
| Education | $170.90 | 5 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences Inc | $7,407 | 14 | $0 (2017) |
| Merck Sharp & Dohme LLC | $151.96 | 5 | $0 (2024) |
| Allergan, Inc. | $133.00 | 3 | $0 (2020) |
| Janssen Biotech, Inc. | $45.61 | 2 | $0 (2017) |
| Medline Industries, Inc. | $43.29 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2023 | $19.81 | 1 | Merck Sharp & Dohme LLC ($19.81) |
| 2020 | $133.00 | 3 | Allergan, Inc. ($133.00) |
| 2017 | $7,610 | 20 | Gilead Sciences Inc ($7,407) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/14/2023 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Education | In-kind items and services | $19.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/18/2020 | Allergan, Inc. | DALVANCE (Drug) | Education | In-kind items and services | $49.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/06/2020 | Allergan, Inc. | DALVANCE (Drug) | Education | In-kind items and services | $42.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2020 | Allergan, Inc. | TEFLARO (Drug) | Education | In-kind items and services | $42.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/08/2017 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 12/08/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $48.78 | General |
| 12/07/2017 | Gilead Sciences Inc | — | Travel and Lodging | In-kind items and services | $342.95 | General |
| 12/07/2017 | Gilead Sciences Inc | — | Travel and Lodging | In-kind items and services | $240.00 | General |
| 12/07/2017 | Gilead Sciences Inc | — | Travel and Lodging | In-kind items and services | $198.62 | General |
| 11/14/2017 | Medline Industries, Inc. | PluroGel Burn & Wound Dressings (Device) | Food and Beverage | In-kind items and services | $43.29 | General |
| Category: Dermatology/Wound Care | ||||||
| 05/31/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/17/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/29/2017 | Janssen Biotech, Inc. | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/28/2017 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $84.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/25/2017 | Gilead Sciences Inc | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $87.97 | General |
| Category: HCV | ||||||
| 01/25/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $558.96 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $282.38 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $220.00 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $49.93 | General |
| Category: HCV | ||||||
| 01/13/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $42.82 | General |
| Category: HCV | ||||||
About Dr. Cezarina Mindru, MD
Dr. Cezarina Mindru, MD is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497780787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cezarina Mindru, MD has received a total of $7,781 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 25 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($5,200).
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Houston, TX
- Active Since 07/12/2006
- Last Updated 05/09/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497780787
Products in Payments
- Epclusa (Drug) $4,377
- DALVANCE (Drug) $91.00
- ZEPATIER (Drug) $84.93
- PREZCOBIX (Drug) $45.61
- PluroGel Burn & Wound Dressings (Device) $43.29
- TEFLARO (Drug) $42.00
- DELSTRIGO (Drug) $19.81
- PREVYMIS (Drug) $18.09
- ZERBAXA (Drug) $15.34
- CUBICIN RF (Drug) $13.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947